tirzepatide argentina 💉 Tirzepatida: Llega a una innovadora droga inyectable contra la obesidad y la diabetes Una nueva herramienta médica revolucionaria está disponible desde este mes en Argentina. Se trata de la tirzepatida Tirzepatide enhances weight loss with

May 27, 2026, 09:00 ET Phase 3 REIMAGINE 13 trial results across a range of type 2 diabetes patient groups offer further insight into CagriSema, a novel amylin RA and a GLP-1 RA in a fixed-dose combination 1 Mid-stage trial data for investigational zenagamtide explore the safety and efficacy of the injectable formulation of the novel GLP-1/amylin-based treatment 2 New Ozempic and Wegovy data provide further evidence of semaglutide's strong cardiometabolic profile PLAINSBORO, NJ and BAGSVRD, Denmark, May 27, 2026 /PRNewswire/ -- Novo Nordisk today announced that new data from its cardiometabolic portfolio and pipeline will be showcased at the upcoming 2026 Scientific Sessions of the American Diabetes Association (ADA), taking place in New Orleans, June 58, 2026

You inject once a week

As we mentioned, these drugs are FDA-approved for different purposes

That number is expected to grow over the coming months